Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Contribution of physiological dynamics in predicting major depressive disorder severity

  • García Pagès, Esther|||0000-0002-9225-845X
  • Kontaxis, Spyridon|||0000-0002-1297-0691
  • Siddi, Sara|||0000-0002-1494-9028
  • Posadas de Miguel, Mar de
  • Cámara, Concepción de la|||0000-0003-2284-7862
  • Bernal, Maria Luisa
  • Castro Ribeiro, Thaís|||0000-0003-2536-7194
  • Laguna, Pablo|||0000-0003-3434-9254
  • Badiella, Llorenç|||0000-0002-9653-7421
  • Bailón, Raquel|||0000-0003-1272-0550
  • Haro Abad, Josep Maria|||0000-0002-3984-277X
  • Aguiló Llobet, Jordi|||0000-0002-4691-5754
This study aimed to explore the physiological dynamics of cognitive stress in patients with Major Depressive Disorder (MDD) and design a multiparametric model for objectively measuring severity of depression. Physiological signal recordings from 40 MDD patients and 40 healthy controls were collected in a baseline stage, in a stress-inducing stage using two cognitive tests, and in the recovery period. Several features were extracted from electrocardiography, photoplethysmography, electrodermal activity, respiration, and temperature. Differences between values of these features under different conditions were used as indexes of autonomic reactivity and recovery. Finally, a linear model was designed to assess MDD severity, using the Beck Depression Inventory scores as the outcome variable. The performance of this model was assessed using the MDD condition as the response variable. General physiological hyporeactivity and poor recovery from stress predict depression severity across all physiological signals except for respiration. The model to predict depression severity included gender, body mass index, cognitive scores, and mean heart rate recovery, and achieved an accuracy of 78%, a sensitivity of 97% and a specificity of 59%. There is an observed correlation between the behavior of the autonomic nervous system, assessed through physiological signals analysis, and depression severity. Our findings demonstrated that decreased autonomic reactivity and recovery are linked with an increased level of depression. Quantifying the stress response together with a cognitive evaluation and personalization variables may facilitate a more precise diagnosis and monitoring of depression, enabling the tailoring of therapeutic interventions to individual patient needs.
Investigo. Repositorio Institucional de la Universidade de Vigo
Publication Contribución de congreso (ConferenceOutput)

Classifying depression symptom severity: assessment of speech representations in personalized and generalized machine learning models

  • Campbell Hernández, Edward Lázaro
  • Dineley, Judith
  • Conde, Pauline
  • Matcham, Faith
  • White, Katie M.
  • Oetzmann, Carolin
  • Simblett, Sara
  • Bruce, Stuart
  • Folarin, Amos A.
  • Wykes, Til
  • Vairavan, Srinivasan
  • Dobson, Richard J. B.
  • Docío Fernández, Laura
  • García Mateo, Carmen
  • Narayan, Vaibhav A.
  • Hotopf, Matthew
  • Cummins, Nicholas
There is an urgent need for new methods that improve the management and treatment of Major Depressive Disorder (MDD). Speech has long been regarded as a promising digital marker in this regard, with many works highlighting that speech changes associated with MDD can be captured through machine learning models. Typically, findings are based on cross-sectional data, with little work exploring the advantages of personalization in building more robust and reliable models. This work assesses the strengths of different combinations of speech representations and machine learning models, in personalized and generalized settings in a two-class depression severity classification paradigm. Key results on a longitudinal dataset highlight the benefits of personalization. Our strongest performing model set-up utilized self-supervised learning features and convolutional neural network (CNN) and long short-term memory (LSTM) back-end., National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre (BRC), South London and Maudsley NHS Foundation Trust, UK Medical Research Council | Ref. MR/N013700/1, King’s College London, Xunta de Galicia | Ref. ED431B 2021/24, Fondo Europeo de Desarrollo Regional
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Barriers to and Facilitators of Engagement With mHealth Technology for Remote Measurement and Management of Depression: Qualitative Analysis

  • Simblett, Sara
  • Matcham, Faith
  • Siddi, Sara
  • Bulgari, Viola
  • Barattieri di San Pietro, C.
  • Hortas López, Jorge
  • Ferrão, José
  • Polhemus, Ashley
  • Haro Abad, Josep Maria
  • de Girolamo, Giovanni
  • Gamble, Peter
  • Eriksson, Hans
  • Hotopf, Matthew
  • Wykes, Til
BACKGROUND: Mobile technology has the potential to provide accurate, impactful data on the symptoms of depression, which could improve health management or assist in early detection of relapse. However, for this potential to be achieved, it is essential that patients engage with the technology. Although many barriers to and facilitators of the use of this technology are common across therapeutic areas and technology types, many may be specific to cultural and health contexts. OBJECTIVE: This study aimed to determine the potential barriers to and facilitators of engagement with mobile health (mHealth) technology for remote measurement and management of depression across three Western European countries. METHODS: Participants (N=25; 4:1 ratio of women to men; age range, 25-73 years) who experienced depression participated in five focus groups held in three countries (two in the United Kingdom, two in Spain, and one in Italy). The focus groups investigated the potential barriers to and facilitators of the use of mHealth technology. A systematic thematic analysis was used to extract themes and subthemes. RESULTS: Facilitators and barriers were categorized as health-related factors, user-related factors, and technology-related factors. A total of 58 subthemes of specific barriers and facilitators or moderators emerged. A core group of themes including motivation, potential impact on mood and anxiety, aspects of inconvenience, and ease of use was noted across all countries. CONCLUSIONS: Similarities in the barriers to and facilitators of the use of mHealth technology have been observed across Spain, Italy, and the United Kingdom. These themes provide guidance on ways to promote the design of feasible and acceptable cross-cultural mHealth tools. ©Sara Simblett, Faith Matcham, Sara Siddi, Viola Bulgari, Chiara Barattieri di San Pietro, Jorge Hortas López, José Ferrão, Ashley Polhemus, Josep Maria Haro, Giovanni de Girolamo, Peter Gamble, Hans Eriksson, Matthew Hotopf, Til Wykes, RADAR-CNS Consortium. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 30.01.2019.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol

  • Matcham, Faith
  • Barattieri di San Pietro, C.
  • Bulgari, V.
  • de Girolamo, G.
  • Dobson, Richard J. B.
  • Eriksson, Hans
  • Folarin, Amos A.
  • Haro Abad, Josep Maria
  • Kerz, J.
  • Lamers, Femke
  • Li, Q.
  • Manyakov, N. V.
  • Mohr, David C.
  • Myin Germeys, Inez
  • Narayan, Vaibhav A.
  • Bwjh, Penninx
  • Ranjan, Yatharth
  • Rashid, Zulqarnain
  • Rintala, Aki
  • Siddi, Sara
  • Simblett, Sara
  • Wykes, Til
  • Hotopf, Matthew
  • RADAR-CNS consortium
BACKGROUND: There is a growing body of literature highlighting the role that wearable and mobile remote measurement technology (RMT) can play in measuring symptoms of major depressive disorder (MDD). Outcomes assessment typically relies on self-report, which can be biased by dysfunctional perceptions and current symptom severity. Predictors of depressive relapse include disrupted sleep, reduced sociability, physical activity, changes in mood, prosody and cognitive function, which are all amenable to measurement via RMT. This study aims to: 1) determine the usability, feasibility and acceptability of RMT; 2) improve and refine clinical outcome measurement using RMT to identify current clinical state; 3) determine whether RMT can provide information predictive of depressive relapse and other critical outcomes. METHODS: RADAR-MDD is a multi-site prospective cohort study, aiming to recruit 600 participants with a history of depressive disorder across three sites: London, Amsterdam and Barcelona. Participants will be asked to wear a wrist-worn activity tracker and download several apps onto their smartphones. These apps will be used to either collect data passively from existing smartphone sensors, or to deliver questionnaires, cognitive tasks, and speech assessments. The wearable device, smartphone sensors and questionnaires will collect data for up to 2-years about participants' sleep, physical activity, stress, mood, sociability, speech patterns, and cognitive function. The primary outcome of interest is MDD relapse, defined via the Inventory of Depressive Symptomatology- Self-Report questionnaire (IDS-SR) and the World Health Organisation's self-reported Composite International Diagnostic Interview (CIDI-SF). DISCUSSION: This study aims to provide insight into the early predictors of major depressive relapse, measured unobtrusively via RMT. If found to be acceptable to patients and other key stakeholders and able to provide clinically useful information predictive of future deterioration, RMT has potential to change the way in which depression and other long-term conditions are measured and managed. KEYWORDS: M-health; Major depressive disorder; Observational cohort; Outcome measurement; Passive sensing; Prospective study; Remote measurement technology
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Investigating the impact of COVID-19 lockdown on adults with a recent history of recurrent major depressive disorder: a multi-Centre study using remote measurement technology.

  • Leightley, Daniel
  • Lavelle, Grace
  • White, Katie M.
  • Sun, Shaoxiong
  • Matcham, Faith
  • Ivan, Alina
  • Oetzmann, Carolin
  • Penninx, Brenda W. J. H.
  • Lamers, Femke
  • Siddi, Sara
  • Haro Abad, Josep Maria
  • Myin Germeys, Inez
  • Bruce, Stuart
  • Nica, Raluca
  • Wickersham, Alice
  • Annas, Peter
  • Mohr, David C.
  • Simblett, Sara
  • Wykes, Til
  • Cummins, Nicholas
  • Folarin, Amos A.
  • Conde, Pauline
  • Ranjan, Yatharth
  • Dobson, Richard J. B.
  • Narayan, Vaibhav A.
  • Hotopf, Mathew
  • RADAR-CNS consortium
Background: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes a clinical illness Covid-19, has had a major impact on mental health globally. Those diagnosed with major depressive disorder (MDD) may be negatively impacted by the global pandemic due to social isolation, feelings of loneliness or lack of access to care. This study seeks to assess the impact of the 1st lockdown - pre-, during and post - in adults with a recent history of MDD across multiple centres. Methods: This study is a secondary analysis of an on-going cohort study, RADAR-MDD project, a multi-centre study examining the use of remote measurement technology (RMT) in monitoring MDD. Self-reported questionnaire and passive data streams were analysed from participants who had joined the project prior to 1st December 2019 and had completed Patient Health and Self-esteem Questionnaires during the pandemic (n = 252). We used mixed models for repeated measures to estimate trajectories of depressive symptoms, self-esteem, and sleep duration. Results: In our sample of 252 participants, 48% (n = 121) had clinically relevant depressive symptoms shortly before the pandemic. For the sample as a whole, we found no evidence that depressive symptoms or self-esteem changed between pre-, during- and post-lockdown. However, we found evidence that mean sleep duration (in minutes) decreased significantly between during- and post- lockdown (- 12.16; 95% CI - 18.39 to - 5.92; p < 0.001). We also found that those experiencing clinically relevant depressive symptoms shortly before the pandemic showed a decrease in depressive symptoms, self-esteem and sleep duration between pre- and during- lockdown (interaction p = 0.047, p = 0.045 and p < 0.001, respectively) as compared to those who were not. Conclusions: We identified changes in depressive symptoms and sleep duration over the course of lockdown, some of which varied according to whether participants were experiencing clinically relevant depressive symptoms shortly prior to the pandemic. However, the results of this study suggest that those with MDD do not experience a significant worsening in symptoms during the first months of the Covid - 19 pandemic.
UPCommons. Portal del coneixement obert de la UPC
Publication Contribución de congreso (ConferenceOutput)

LSTM neural network-based speaker segmentation using acoustic and language modelling

  • India Massana, Miquel Àngel|||0000-0002-3107-3662
  • Rodríguez Fonollosa, José Adrián|||0000-0001-9513-7939
  • Hernando Pericás, Francisco Javier|||0000-0002-1730-8154
This paper presents a new speaker change detection system based on Long Short-Term Memory (LSTM) neural networks using acoustic data and linguistic content. Language modelling is combined with two different Joint Factor Analysis (JFA) acoustic approaches: i-vectors and speaker factors. Both of them are compared with a baseline algorithm that uses cosine distance to detect speaker turn changes. LSTM neural networks with both linguistic and acoustic features have been able to produce a robust speaker segmentation. The experimental results show that our proposal clearly outperforms the baseline system., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Pre-and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study

  • Ibáñez Salvador, Delia
  • Condominas i Casanovas, Elena|||0000-0002-7178-8398
  • Haro, Josep Maria
  • Giné Vázquez, Iago
  • Bailón Luesma, Raquel
  • García Pagès, Esther
  • Kontaxis, Spyridon
  • Peñarrubia Maria, Maria Teresa
  • Arranz, Belen
  • Llaosa Scholten, Raúl
  • Gardeñes, Lluisa
  • Hotopf, Matthew
  • Matcham, Faith
  • Lamers, Femke
  • Penninx, Brenda
  • Annas, Peter
  • Folarin, Amos
  • Narayan, Vaibhav
  • Antunes Lima, Rodrigo
  • Siddi, Sara
Aim: To evaluate the longitudinal association of sedentary behavior, light and moderate-to-vigorous physical activity (MVPA) participation with depressive symptoms and whether their possible association changed depending on the pandemic phase. Methods: This longitudinal study conducted secondary analysis from the Spanish cohort of the Remote Assessment of Disease and Relapse – Major Depressive Disorder (RADAR-MDD) study. Depressive symptoms were assessed by the Patient Health Questionnaire (PHQ-8). Sedentary behavior and physical activity were estimated via wrist-worn devices. Linear mixed models evaluated the longitudinal associations of sedentary behavior and physical activity (light and moderate-to-vigorous intensities) with depressive symptoms. Results: In total, 95 participants (67.5% women, 53.0 [±10.5] years of age on average) were monitored pre-COVID-19 and included in the analyses. Pre-COVID-19, 73.7% of participants presented depression, and, on average, participated in 13.2 (±1.08) hours/day of sedentary behavior, 2.42 (±0.90) hours/day of light physical activity and 23.6 (±19.80) minutes/day of MVPA. Considering all the observations (from November 2019 to October 2020), an additional hour/day of sedentary behavior was longitudinally associated with higher depressive symptoms [ßstd¿=¿0.06, 95% confidence interval (CI) 0.10 to 0.47], whereas an additional hour/day in light physical activity was associated with lower depressive symptoms (ßstd¿=¿-0.06, 95% CI -0.59 to -0.15). Time in MVPA was not associated with depressive symptomatology. The association of sedentary behavior and light physical activity with depressive symptoms was significant only during pre-COVID-19 and COVID-19 relaxation periods, whereas during the strictest periods of the pandemic with regards to the restrictions (lockdown and de-escalation), the association was not observed. Conclusion: Sedentary behavior and light physical activity were longitudinally associated with depressive symptoms in participants with a history of MDD. The incorporation of light physical activity should be stimulated in adults with a history of MDD. Neither sedentary behavior nor light physical activity were associated with depressive symptoms during the most restrictive COVID-19 phases, whereas sedentary behavior (positively) and light physical activity (negatively) were associated with depressive symptoms in persons with MDD before and after the COVID-19 pandemic., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The RADAR-CNS project received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA (www.imi.europa.eu). This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein. RAL received the IHMC22/00003, funded by Instituto de Salud Carlos III and funds Next Generation Eu, which finance the actions of the Recovery and Recovery Mechanism Resilience (MRR). The funding body was not involved in the design, analysis or interpretation of data of this study., Peer Reviewed, Membres del RADAR-MDD-Spain: Peñarrubia-Maria, Maria Teresa; Gardeñes Moron, Lluisa; Jugo, Beatriz; Orive , Cristina; De Miguel, Blanca; Blanco, Elena; Gallardo, Cristina; Cobo-Guerrero, Silvia; Molero, Aida; Belvis Mariscal, Cristina; Martinez, Gemma; Valdés, Raúl; Torres-Martinez, Rebecca; López, Fran; Mera-Cordero, Francisco; Soraluce Acebo, Ramón; Sarró, Marta; Moliner-Molina, Cristina; Flores, Maria Rosa; Sostres, Susana; Ait Ben, Aissa; Poch, Marta; Olmos, Maria Cristina; Ortiz Navarrete, Sónia; Martinez, Andrea; Freixas, Olga; Caldón, Beatriz; Cano, Maria Isabel; Lombardini, Federica; Coromina, Marta; Arranz, Belen; Arranz, Sara; Salvador, Laia; Hernandez, Carla; Marqueta-Marqués, Cristina; Calamardo, Elisabet; Ferenc, Tamas; Rubio-Alacid, Elena; Rojas, Antonio; Druetta, Mauro; Marso, Esperança; Hernandez-Fernandez, Elisabet; Cuñat, Oriol; Otero, Begoña; Tronchoni, Mónica; Tessari, Diego; Labarta, Eugenia; Delisau, Yaiza; Angelats, Marina; Vilella, Elisabet; Llaosa-Scholten, Raúl; Adam, Noemí; Reneses Prieto, Blanca and Zamarro Arranz, Maria Luisa.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Biopsychosocial response to the COVID-19 lockdown in people with major depressive disorder and multiple sclerosis

  • Siddi, Sara
  • Giné Vázquez, Iago
  • Bailon, Raquel
  • Matcham, Faith
  • Lamers, Femke
  • Kontaxis, Spyridon
  • Laporta, Estela
  • Garcia, Esther
  • Arranz, Belen
  • Dalla Costa, Gloria
  • Guerrero, Ana Isabel
  • Zabalza, Ana
  • Buron, Mathias Due
  • Comi, Giancarlo
  • Leocani, Letizia
  • Annas, Peter
  • Hotopf, Matthew
  • Penninx, Brenda W. J. H.
  • Magyari, Melinda
  • Sørensen, Per S.
  • Montalban, Xavier
  • Lavelle, Grace
  • Ivan, Alina
  • Oetzmann, Carolin
  • White, Katie M.
  • Difrancesco, Sonia
  • Locatelli, Patrick
  • Mohr, David C.
  • Aguiló, Jordi
  • Narayan, Vaibhav
  • Folarin, Amos
  • Dobson, Richard J. B.
  • Dineley, Judith
  • Leightley, Daniel
  • Cummins, Nicholas
  • Vairavan, Srinivasan
  • Ranjan, Yathart
  • Rashid, Zulqarnain
  • Rintala, Aki
  • Girolamo, Giovanni De
  • Preti, Antonio
  • Simblett, Sara
  • Wykes, Til
  • Myin-Germeys, Inez
  • Haro, Josep Maria
Background: Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS). Methods: Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse—Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Results: Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Conclusions: Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The impact of COVID-19 lockdown on adults with major depressive disorder from Catalonia: a decentralized longitudinal study

  • Lavalle, Raffaele
  • Condominas, Elena
  • Haro, Josep Maria
  • Giné-Vázquez, Iago
  • Bailon, Raquel
  • Laporta, Estela
  • Garcia, Ester
  • Kontaxis, Spyridon
  • Riquelme Alacid, Gemma
  • Lombardini, Federica
  • Preti, Antonio
  • Peñarrubia-Maria, Maria Teresa
  • Coromina, Marta
  • Arranz, Belén
  • Vilella, Elisabet
  • Rubio-Alacid, Elena
  • Matcham, Faith
  • Lamers, Femke
  • Hotopf, Matthew
  • Penninx, Brenda W. J. H.
  • Annas, Peter
  • Narayan, Vaibhav
  • Simblett, Sara K.
  • Siddi, Sara
  • RADAR-CNS Consortium
The present study analyzes the effects of each containment phase of the first COVID-19 wave on depression levels in a cohort of 121 adults with a history of major depressive disorder (MDD) from Catalonia recruited from 1 November 2019, to 16 October 2020. This analysis is part of the Remote Assessment of Disease and Relapse-MDD (RADAR-MDD) study. Depression was evaluated with the Patient Health Questionnaire-8 (PHQ-8), and anxiety was evaluated with the Generalized Anxiety Disorder-7 (GAD-7). Depression’s levels were explored across the phases (pre-lockdown, lockdown, and four post-lockdown phases) according to the restrictions of Spanish/Catalan governments. Then, a mixed model was fitted to estimate how depression varied over the phases. A significant rise in depression severity was found during the lockdown and phase 0 (early post-lockdown), compared with the pre-lockdown. Those with low pre-lockdown depression experienced an increase in depression severity during the “new normality”, while those with high pre-lockdown depression decreased compared with the pre-lockdown. These findings suggest that COVID-19 restrictions affected the depression level depending on their pre-lockdown depression severity. Individuals with low levels of depression are more reactive to external stimuli than those with more severe depression, so the lockdown may have worse detrimental effects on them.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis

  • Kontaxis, Spyridon
  • Laporta, Estela
  • Garcia, Esther
  • Guerrero, Ana Isabel
  • Zabalza, Ana
  • Matteo, Martinis
  • Lucia, Roselli
  • Simblett, Sara
  • Weyer, Janice
  • Hotopf, Matthew
  • Narayan, Vaibhav A.
  • Rashid, Zulqarnain
  • Folarin, Amos A.
  • Dobson, Richard J. B.
  • Buron, Mathias Due
  • Leocani, Letizia
  • Cummins, Nicholas
  • Vairavan, Srinivasan
  • Costa, Gloria Dalla
  • Magyari, Melinda
  • Sørensen, Per Soelberg
  • Nos, Carlos
  • Bailón, Raquel
  • Comi, Giancarlo
  • the RADAR-CNS Consortium
Objective: The aim of this study was to evaluate the association between changes in the autonomic control of cardiorespiratory system induced by walk tests and outcome measures in people with Multiple Sclerosis (pwMS).Methods: Electrocardiogram (ECG) recordings of 148 people with Relapsing-Remitting MS (RRMS) and 58 with Secondary Progressive MS (SPMS) were acquired using a wearable device before, during, and after walk test performance from a total of 386 periodical clinical visits. A subset of 90 participants repeated a walk test at home. Various MS-related symptoms, including fatigue, disability, and walking capacity were evaluated at each clinical visit, while heart rate variability (HRV) and ECG-derived respiration (EDR) were analyzed to assess autonomic nervous system (ANS) function. Statistical tests were conducted to assess differences in ANS control between pwMS grouped based on the phenotype or the severity of MS-related symptoms. Furthermore, correlation coefficients (r) were calculated to assess the association between the most significant ANS parameters and MS-outcome measures.Results: People with SPMS, compared to RRMS, reached higher mean heart rate (HRM) values during walk test, and larger sympathovagal balance after test performance. Furthermore, pwMS who were able to adjust their HRM and ventilatory values, such as respiratory rate and standard deviation of the ECG-derived respiration, were associated with better clinical outcomes. Correlation analyses showed weak associations between ANS parameters and clinical outcomes when the Multiple Sclerosis phenotype is not taken into account. Blunted autonomic response, in particular HRM reactivity, was related with worse walking capacity, yielding r = 0.36 r = 0.29 (RRMS) and r > 0.5 (SPMS). A positive strong correlation r > 0.7 r > 0.65 between cardiorespiratory parameters derived at hospital and at home was also found.Conclusion: Autonomic function, as measured by HRV, differs according to MS phenotype. Autonomic response to walk tests may be useful for assessing clinical outcomes, mainly in the progressive stage of MS. Participants with larger changes in HRM are able to walk longer distance, while reduced ventilatory function during and after walk test performance is associated with higher fatigue and disability severity scores. Monitoring of disorder severity could also be feasible using ECG-derived cardiac and respiratory parameters recorded with a wearable device at home.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Automatic assessment of the 2-minute walk distance for remote monitoring of people with multiple sclerosis

  • Kontaxis, Spyridon
  • Laporta, Estela
  • Garcia, Esther
  • Martinis, Matteo
  • Leocani, Letizia
  • Roselli, Lucia
  • Buron, Mathias Due
  • Guerrero, Ana Isabel
  • Zabala, Ana
  • Cummins, Nicholas
  • Vairavan, Srinivasan
  • Hotopf, Matthew
  • Dobson, Richard J. B.
  • Narayan, Vaibhav A.
  • La Porta, Maria Libera
  • Costa, Gloria Dalla
  • Magyari, Melinda
  • Sørensen, Per Soelberg
  • Nos, Carlos
  • Bailon, Raquel
  • Comi, Giancarlo
The aim of this study was to investigate the feasibility of automatically assessing the 2-Minute Walk Distance (2MWD) for monitoring people with multiple sclerosis (pwMS). For 154 pwMS, MS-related clinical outcomes as well as the 2MWDs as evaluated by clinicians and derived from accelerometer data were collected from a total of 323 periodic clinical visits. Accelerometer data from a wearable device during 100 home-based 2MWD assessments were also acquired. The error in estimating the 2MWD was validated for walk tests performed at hospital, and then the correlation (r) between clinical outcomes and home-based 2MWD assessments was evaluated. Robust performance in estimating the 2MWD from the wearable device was obtained, yielding an error of less than 10% in about two-thirds of clinical visits. Correlation analysis showed that there is a strong association between the actual and the estimated 2MWD obtained either at hospital (r = 0.71) or at home (r = 0.58). Furthermore, the estimated 2MWD exhibits moderate-to-strong correlation with various MS-related clinical outcomes, including disability and fatigue severity scores. Automatic assessment of the 2MWD in pwMS is feasible with the usage of a consumer-friendly wearable device in clinical and non-clinical settings. Wearable devices can also enhance the assessment of MS-related clinical outcomes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severity

  • Siddi, S.
  • Bailón, R.
  • Giné-Vázquez, I.
  • Matcham, F.
  • Lamers, F.
  • Kontaxis, S.
  • Laporta, E.
  • García, E.
  • Lombardini, F.
  • Annas, P.
  • Hotopf, M.
  • Penninx, B. W. J. H.
  • Ivan, A.
  • White, K. M.
  • Difrancesco, S.
  • Locatelli, P.
  • Aguiló, J.
  • Peñarrubia-Maria, M. T.
  • Narayan, V. A.
  • Folarin, A.
  • Leightley, D.
  • Cummins, N.
  • Vairavan, S.
  • Ranjan, Y.
  • Rintala, A.
  • De Girolamo, G.
  • Simblett, S. K.
  • Wykes, T.
  • Myin-Germeys, I.
  • Dobson, R.
  • Haro, J. M.
  • PAB members
Background: Alterations in heart rate (HR) may provide new information about physiological signatures of depression severity. This 2-year study in individuals with a history of recurrent major depressive disorder (MDD) explored the intra-individual variations in HR parameters and their relationship with depression severity. Methods: Data from 510 participants (Number of observations of the HR parameters = 6666) were collected from three centres in the Netherlands, Spain, and the UK, as a part of the remote assessment of disease and relapse-MDD study. We analysed the relationship between depression severity, assessed every 2 weeks with the Patient Health Questionnaire-8, with HR parameters in the week before the assessment, such as HR features during all day, resting periods during the day and at night, and activity periods during the day evaluated with a wrist-worn Fitbit device. Linear mixed models were used with random intercepts for participants and countries. Covariates included in the models were age, sex, BMI, smoking and alcohol consumption, antidepressant use and co-morbidities with other medical health conditions. Results: Decreases in HR variation during resting periods during the day were related with an increased severity of depression both in univariate and multivariate analyses. Mean HR during resting at night was higher in participants with more severe depressive symptoms. Conclusions: Our findings demonstrate that alterations in resting HR during all day and night are associated with depression severity. These findings may provide an early warning of worsening depression symptoms which could allow clinicians to take responsive treatment measures promptly.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Multilingual markers of depression in remotely collected speech samples: A preliminary analysis

  • Cummins, Nicholas
  • Dineley, Judith
  • Conde, Pauline
  • Matcham, Faith
  • Siddi, Sara
  • Lamers, Femke
  • Carr, Ewan
  • Lavelle, Grace
  • Leightley, Daniel
  • White, Katie M.
  • Oetzmann, Carolin
  • Campbell, Edward L.
  • Simblett, Sara
  • Bruce, Stuart
  • Haro, Josep Maria
  • Penninx, Brenda W.J.H.
  • Ranjan, Yatharth
  • Rashid, Zulqarnain
  • Stewart, Callum
  • Folarin, Amos A.
  • Bailón, Raquel
  • Schuller, Björn W.
  • Wykes, Til
  • Vairavan, Srinivasan
  • Dobson, Richard J.B.
  • Narayan, Vaibhav A.
  • Hotopf, Matthew
Background: Speech contains neuromuscular, physiological and cognitive components, and so is a potential biomarker of mental disorders. Previous studies indicate that speaking rate and pausing are associated with major depressive disorder (MDD). However, results are inconclusive as many studies are small and underpowered and do not include clinical samples. These studies have also been unilingual and use speech collected in controlled settings. If speech markers are to help understand the onset and progress of MDD, we need to uncover markers that are robust to language and establish the strength of associations in real-world data. Methods: We collected speech data in 585 participants with a history of MDD in the United Kingdom, Spain, and Netherlands as part of the RADAR-MDD study. Participants recorded their speech via smartphones every two weeks for 18 months. Linear mixed models were used to estimate the strength of specific markers of depression from a set of 28 speech features. Results: Increased depressive symptoms were associated with speech rate, articulation rate and intensity of speech elicited from a scripted task. These features had consistently stronger effect sizes than pauses. Limitations: Our findings are derived at the cohort level so may have limited impact on identifying intra-individual speech changes associated with changes in symptom severity. The analysis of features averaged over the entire recording may have underestimated the importance of some features. Conclusions: Participants with more severe depressive symptoms spoke more slowly and quietly. Our findings are from a real-world, multilingual, clinical dataset so represent a step-change in the usefulness of speech as a digital phenotype of MDD.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Contribution of physiological dynamics in predicting major depressive disorder severity

  • Pagès, Esther García
  • Kontaxis, Spyridon
  • Siddi, Sara
  • Posadas de Miguel, Mar
  • Cámara, Concepción de la
  • Bernal, Maria Luisa
  • Ribeiro, Thais Castro
  • Laguna, Pablo
  • Badiella, Llorenç
  • Bailón, Raquel
  • Haro, Josep Maria
  • Aguiló, Jordi
This study aimed to explore the physiological dynamics of cognitive stress in patients with Major Depressive Disorder (MDD) and design a multiparametric model for objectively measuring severity of depression. Physiological signal recordings from 40 MDD patients and 40 healthy controls were collected in a baseline stage, in a stress‐inducing stage using two cognitive tests, and in the recovery period. Several features were extracted from electrocardiography, photoplethysmography, electrodermal activity, respiration, and temperature. Differences between values of these features under different conditions were used as indexes of autonomic reactivity and recovery. Finally, a linear model was designed to assess MDD severity, using the Beck Depression Inventory scores as the outcome variable. The performance of this model was assessed using the MDD condition as the response variable. General physiological hyporeactivity and poor recovery from stress predict depression severity across all physiological signals except for respiration. The model to predict depression severity included gender, body mass index, cognitive scores, and mean heart rate recovery, and achieved an accuracy of 78%, a sensitivity of 97% and a specificity of 59%. There is an observed correlation between the behavior of the autonomic nervous system, assessed through physiological signals analysis, and depression severity. Our findings demonstrated that decreased autonomic reactivity and recovery are linked with an increased level of depression. Quantifying the stress response together with a cognitive evaluation and personalization variables may facilitate a more precise diagnosis and monitoring of depression, enabling the tailoring of therapeutic interventions to individual patient needs.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Pre- and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study

  • Ibáñez, Delia
  • Condominas, Elena
  • Haro, Josep Maria
  • Vázquez, Iago Giné
  • RADAR-MDD-Spain
  • Bailón, Raquel
  • Garcia, Esther
  • Kontaxis, Spyridon
  • Peñarrubia-Maria, Maria Teresa
  • Arranz, Belen
  • Llaosa-Scholten, Raúl
  • Gardeñes, Lluisa
  • Hotopf, Matthew
  • Matcham, Faith
  • Lamers, Femke
  • Penninx, Brenda W. J. H.
  • Annas, Peter
  • Folarin, Amos
  • Narayan, Vaibhav
  • Antunes Lima, Rodrigo
  • Siddi, Sara
AimTo evaluate the longitudinal association of sedentary behavior, light and moderate-to-vigorous physical activity (MVPA) participation with depressive symptoms and whether their possible association changed depending on the pandemic phase.MethodsThis longitudinal study conducted secondary analysis from the Spanish cohort of the Remote Assessment of Disease and Relapse – Major Depressive Disorder (RADAR-MDD) study. Depressive symptoms were assessed by the Patient Health Questionnaire (PHQ-8). Sedentary behavior and physical activity were estimated via wrist-worn devices. Linear mixed models evaluated the longitudinal associations of sedentary behavior and physical activity (light and moderate-to-vigorous intensities) with depressive symptoms.ResultsIn total, 95 participants (67.5% women, 53.0 [±10.5] years of age on average) were monitored pre-COVID-19 and included in the analyses. Pre-COVID-19, 73.7% of participants presented depression, and, on average, participated in 13.2 (±1.08) hours/day of sedentary behavior, 2.42 (±0.90) hours/day of light physical activity and 23.6 (±19.80) minutes/day of MVPA. Considering all the observations (from November 2019 to October 2020), an additional hour/day of sedentary behavior was longitudinally associated with higher depressive symptoms [βstd = 0.06, 95% confidence interval (CI) 0.10 to 0.47], whereas an additional hour/day in light physical activity was associated with lower depressive symptoms (βstd = −0.06, 95% CI −0.59 to −0.15). Time in MVPA was not associated with depressive symptomatology. The association of sedentary behavior and light physical activity with depressive symptoms was significant only during pre-COVID-19 and COVID-19 relaxation periods, whereas during the strictest periods of the pandemic with regards to the restrictions (lockdown and de-escalation), the association was not observed.ConclusionSedentary behavior and light physical activity were longitudinally associated with depressive symptoms in participants with a history of MDD. The incorporation of light physical activity should be stimulated in adults with a history of MDD. Neither sedentary behavior nor light physical activity were associated with depressive symptoms during the most restrictive COVID-19 phases, whereas sedentary behavior (positively) and light physical activity (negatively) were associated with depressive symptoms in persons with MDD before and after the COVID-19 pandemic.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Multilingual lexical feature analysis of spoken language for predicting major depression symptom severity

  • Tokareva, Anastasiia
  • Dineley, Judith
  • Firth, Zoë
  • Conde, Pauline
  • Matcham, Faith
  • Siddi, Sara
  • Lamers, Femke
  • Carr, Ewan
  • Oetzmann, Carolin
  • Leightley, Daniel
  • Zhang, Yuezhou
  • Folarin, Amos A.
  • Haro, Josep Maria
  • Penninx, Brenda W.J.H.
  • Bailon, Raquel
  • Vairavan, Srinivasan
  • Wykes, Til
  • Dobson, Richard J.B.
  • Narayan, Vaibhav A.
  • Hotopf, Matthew
  • Cummins, Nicholas
Background Remotely captured spoken language could provide objective, regular indicators of depression symptom severity. However, research to date has largely used non-clinical, cross-sectional written language and complex machine learning (ML) approaches with limited interpretability. Methods We used linear mixed-effect models to identify interpretable lexical features associated with symptom severity in data from the RADAR-MDD study that comprised 5846 smartphone recordings and Patient Health Questionnaire (PHQ-8) scores from 467 participants in the UK, Netherlands and Spain. We then developed ML models and systematically assessed via nested cross-validation whether interpretable lexical features or high-dimensional vector embeddings improved the accuracy of PHQ-8 prediction over sociodemographic and confounding features. Results Depression symptom severity was associated with five lexical features, including reductions in word count measures, use of first-person plural pronouns and positive word frequency. Associations were stable across countries, except for positive word frequency. Lexical features and vector embeddings did improve prediction accuracy beyond baseline models. Limitations Our cohort was skewed in age (median = 53, IQR 35 to 62) and majority female (n = 357), potentially affecting the generalizability of our results. A lack of natural language processing tools for non-English languages restricted our feature choices. Conclusion Further research is required to realise the value of spoken lexical markers in clinical research and practice including larger and more diverse samples, elicitation protocol development and analytical methods that account for within- and between-individual variations.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pre-and post-COVID 19 outbreak relationship between physical activity and depressive symptoms in Spanish adults with major depressive disorder: a secondary analysis of the RADAR-MDD cohort study

  • Ibáñez Salvador, Delia
  • Condominas i Casanovas, Elena
  • Haro, Josep Maria
  • Giné Vázquez, Iago
  • Bailón Luesma, Raquel
  • García Pagès, Esther
  • Kontaxis, Spyridon
  • Peñarrubia Maria, Maria Teresa
  • Arranz, Belen
  • Llaosa Scholten, Raúl
  • Gardeñes, Lluisa
  • Hotopf, Matthew
  • Matcham, Faith
  • Lamers, Femke
  • Penninx, Brenda
  • Annas, Peter
  • Folarin, Amos
  • Narayan, Vaibhav
  • Antunes Lima, Rodrigo
  • Siddi, Sara
Aim: To evaluate the longitudinal association of sedentary behavior, light and moderate-to-vigorous physical activity (MVPA) participation with depressive symptoms and whether their possible association changed depending on the pandemic phase. Methods: This longitudinal study conducted secondary analysis from the Spanish cohort of the Remote Assessment of Disease and Relapse – Major Depressive Disorder (RADAR-MDD) study. Depressive symptoms were assessed by the Patient Health Questionnaire (PHQ-8). Sedentary behavior and physical activity were estimated via wrist-worn devices. Linear mixed models evaluated the longitudinal associations of sedentary behavior and physical activity (light and moderate-to-vigorous intensities) with depressive symptoms. Results: In total, 95 participants (67.5% women, 53.0 [±10.5] years of age on average) were monitored pre-COVID-19 and included in the analyses. Pre-COVID-19, 73.7% of participants presented depression, and, on average, participated in 13.2 (±1.08) hours/day of sedentary behavior, 2.42 (±0.90) hours/day of light physical activity and 23.6 (±19.80) minutes/day of MVPA. Considering all the observations (from November 2019 to October 2020), an additional hour/day of sedentary behavior was longitudinally associated with higher depressive symptoms [ßstd¿=¿0.06, 95% confidence interval (CI) 0.10 to 0.47], whereas an additional hour/day in light physical activity was associated with lower depressive symptoms (ßstd¿=¿-0.06, 95% CI -0.59 to -0.15). Time in MVPA was not associated with depressive symptomatology. The association of sedentary behavior and light physical activity with depressive symptoms was significant only during pre-COVID-19 and COVID-19 relaxation periods, whereas during the strictest periods of the pandemic with regards to the restrictions (lockdown and de-escalation), the association was not observed. Conclusion: Sedentary behavior and light physical activity were longitudinally associated with depressive symptoms in participants with a history of MDD. The incorporation of light physical activity should be stimulated in adults with a history of MDD. Neither sedentary behavior nor light physical activity were associated with depressive symptoms during the most restrictive COVID-19 phases, whereas sedentary behavior (positively) and light physical activity (negatively) were associated with depressive symptoms in persons with MDD before and after the COVID-19 pandemic., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The RADAR-CNS project received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA (www.imi.europa.eu). This communication reflects the views of the RADAR-CNS consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein. RAL received the IHMC22/00003, funded by Instituto de Salud Carlos III and funds Next Generation Eu, which finance the actions of the Recovery and Recovery Mechanism Resilience (MRR). The funding body was not involved in the design, analysis or interpretation of data of this study., Peer Reviewed, Membres del RADAR-MDD-Spain: Peñarrubia-Maria, Maria Teresa; Gardeñes Moron, Lluisa; Jugo, Beatriz; Orive , Cristina; De Miguel, Blanca; Blanco, Elena; Gallardo, Cristina; Cobo-Guerrero, Silvia; Molero, Aida; Belvis Mariscal, Cristina; Martinez, Gemma; Valdés, Raúl; Torres-Martinez, Rebecca; López, Fran; Mera-Cordero, Francisco; Soraluce Acebo, Ramón; Sarró, Marta; Moliner-Molina, Cristina; Flores, Maria Rosa; Sostres, Susana; Ait Ben, Aissa; Poch, Marta; Olmos, Maria Cristina; Ortiz Navarrete, Sónia; Martinez, Andrea; Freixas, Olga; Caldón, Beatriz; Cano, Maria Isabel; Lombardini, Federica; Coromina, Marta; Arranz, Belen; Arranz, Sara; Salvador, Laia; Hernandez, Carla; Marqueta-Marqués, Cristina; Calamardo, Elisabet; Ferenc, Tamas; Rubio-Alacid, Elena; Rojas, Antonio; Druetta, Mauro; Marso, Esperança; Hernandez-Fernandez, Elisabet; Cuñat, Oriol; Otero, Begoña; Tronchoni, Mónica; Tessari, Diego; Labarta, Eugenia; Delisau, Yaiza; Angelats, Marina; Vilella, Elisabet; Llaosa-Scholten, Raúl; Adam, Noemí; Reneses Prieto, Blanca and Zamarro Arranz, Maria Luisa., Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): a multi-centre prospective cohort study protocol

  • Matcham, Faith
  • Barattieri di San Pietro, C.
  • Bulgari, V.
  • de Girolamo, G.
  • Dobson, Richard J. B.
  • Eriksson, Hans
  • Folarin, Amos A.
  • Haro Abad, Josep Maria
  • Kerz, J.
  • Lamers, Femke
  • Li, Q.
  • Manyakov, N. V.
  • Mohr, David C.
  • Myin Germeys, Inez
  • Narayan, Vaibhav A.
  • Bwjh, Penninx
  • Ranjan, Yatharth
  • Rashid, Zulqarnain
  • Rintala, Aki
  • Siddi, Sara
  • Simblett, Sara
  • Wykes, Til
  • Hotopf, Matthew
  • RADAR-CNS consortium
BACKGROUND: There is a growing body of literature highlighting the role that wearable and mobile remote measurement technology (RMT) can play in measuring symptoms of major depressive disorder (MDD). Outcomes assessment typically relies on self-report, which can be biased by dysfunctional perceptions and current symptom severity. Predictors of depressive relapse include disrupted sleep, reduced sociability, physical activity, changes in mood, prosody and cognitive function, which are all amenable to measurement via RMT. This study aims to: 1) determine the usability, feasibility and acceptability of RMT; 2) improve and refine clinical outcome measurement using RMT to identify current clinical state; 3) determine whether RMT can provide information predictive of depressive relapse and other critical outcomes. METHODS: RADAR-MDD is a multi-site prospective cohort study, aiming to recruit 600 participants with a history of depressive disorder across three sites: London, Amsterdam and Barcelona. Participants will be asked to wear a wrist-worn activity tracker and download several apps onto their smartphones. These apps will be used to either collect data passively from existing smartphone sensors, or to deliver questionnaires, cognitive tasks, and speech assessments. The wearable device, smartphone sensors and questionnaires will collect data for up to 2-years about participants' sleep, physical activity, stress, mood, sociability, speech patterns, and cognitive function. The primary outcome of interest is MDD relapse, defined via the Inventory of Depressive Symptomatology- Self-Report questionnaire (IDS-SR) and the World Health Organisation's self-reported Composite International Diagnostic Interview (CIDI-SF). DISCUSSION: This study aims to provide insight into the early predictors of major depressive relapse, measured unobtrusively via RMT. If found to be acceptable to patients and other key stakeholders and able to provide clinically useful information predictive of future deterioration, RMT has potential to change the way in which depression and other long-term conditions are measured and managed. KEYWORDS: M-health; Major depressive disorder; Observational cohort; Outcome measurement; Passive sensing; Prospective study; Remote measurement technology
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Investigating the impact of COVID-19 lockdown on adults with a recent history of recurrent major depressive disorder: a multi-Centre study using remote measurement technology.

  • Leightley, Daniel
  • Lavelle, Grace
  • White, Katie M.
  • Sun, Shaoxiong
  • Matcham, Faith
  • Ivan, Alina
  • Oetzmann, Carolin
  • Penninx, Brenda W. J. H.
  • Lamers, Femke
  • Siddi, Sara
  • Haro Abad, Josep Maria
  • Myin Germeys, Inez
  • Bruce, Stuart
  • Nica, Raluca
  • Wickersham, Alice
  • Annas, Peter
  • Mohr, David C.
  • Simblett, Sara
  • Wykes, Til
  • Cummins, Nicholas
  • Folarin, Amos A.
  • Conde, Pauline
  • Ranjan, Yatharth
  • Dobson, Richard J. B.
  • Narayan, Vaibhav A.
  • Hotopf, Mathew
  • RADAR-CNS consortium
Background: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes a clinical illness Covid-19, has had a major impact on mental health globally. Those diagnosed with major depressive disorder (MDD) may be negatively impacted by the global pandemic due to social isolation, feelings of loneliness or lack of access to care. This study seeks to assess the impact of the 1st lockdown - pre-, during and post - in adults with a recent history of MDD across multiple centres. Methods: This study is a secondary analysis of an on-going cohort study, RADAR-MDD project, a multi-centre study examining the use of remote measurement technology (RMT) in monitoring MDD. Self-reported questionnaire and passive data streams were analysed from participants who had joined the project prior to 1st December 2019 and had completed Patient Health and Self-esteem Questionnaires during the pandemic (n = 252). We used mixed models for repeated measures to estimate trajectories of depressive symptoms, self-esteem, and sleep duration. Results: In our sample of 252 participants, 48% (n = 121) had clinically relevant depressive symptoms shortly before the pandemic. For the sample as a whole, we found no evidence that depressive symptoms or self-esteem changed between pre-, during- and post-lockdown. However, we found evidence that mean sleep duration (in minutes) decreased significantly between during- and post- lockdown (- 12.16; 95% CI - 18.39 to - 5.92; p < 0.001). We also found that those experiencing clinically relevant depressive symptoms shortly before the pandemic showed a decrease in depressive symptoms, self-esteem and sleep duration between pre- and during- lockdown (interaction p = 0.047, p = 0.045 and p < 0.001, respectively) as compared to those who were not. Conclusions: We identified changes in depressive symptoms and sleep duration over the course of lockdown, some of which varied according to whether participants were experiencing clinically relevant depressive symptoms shortly prior to the pandemic. However, the results of this study suggest that those with MDD do not experience a significant worsening in symptoms during the first months of the Covid - 19 pandemic.
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

LSTM neural network-based speaker segmentation using acoustic and language modelling

  • India Massana, Miquel Àngel
  • Rodríguez Fonollosa, José Adrián
  • Hernando Pericás, Francisco Javier
This paper presents a new speaker change detection system based on Long Short-Term Memory (LSTM) neural networks using acoustic data and linguistic content. Language modelling is combined with two different Joint Factor Analysis (JFA) acoustic approaches: i-vectors and speaker factors. Both of them are compared with a baseline algorithm that uses cosine distance to detect speaker turn changes. LSTM neural networks with both linguistic and acoustic features have been able to produce a robust speaker segmentation. The experimental results show that our proposal clearly outperforms the baseline system., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Barriers to and Facilitators of Engagement With mHealth Technology for Remote Measurement and Management of Depression: Qualitative Analysis

  • Simblett, Sara
  • Matcham, Faith
  • Siddi, Sara
  • Bulgari, Viola
  • Barattieri di San Pietro, C.
  • Hortas López, Jorge
  • Ferrão, José
  • Polhemus, Ashley
  • Haro Abad, Josep Maria
  • de Girolamo, Giovanni
  • Gamble, Peter
  • Eriksson, Hans
  • Hotopf, Matthew
  • Wykes, Til
BACKGROUND: Mobile technology has the potential to provide accurate, impactful data on the symptoms of depression, which could improve health management or assist in early detection of relapse. However, for this potential to be achieved, it is essential that patients engage with the technology. Although many barriers to and facilitators of the use of this technology are common across therapeutic areas and technology types, many may be specific to cultural and health contexts. OBJECTIVE: This study aimed to determine the potential barriers to and facilitators of engagement with mobile health (mHealth) technology for remote measurement and management of depression across three Western European countries. METHODS: Participants (N=25; 4:1 ratio of women to men; age range, 25-73 years) who experienced depression participated in five focus groups held in three countries (two in the United Kingdom, two in Spain, and one in Italy). The focus groups investigated the potential barriers to and facilitators of the use of mHealth technology. A systematic thematic analysis was used to extract themes and subthemes. RESULTS: Facilitators and barriers were categorized as health-related factors, user-related factors, and technology-related factors. A total of 58 subthemes of specific barriers and facilitators or moderators emerged. A core group of themes including motivation, potential impact on mood and anxiety, aspects of inconvenience, and ease of use was noted across all countries. CONCLUSIONS: Similarities in the barriers to and facilitators of the use of mHealth technology have been observed across Spain, Italy, and the United Kingdom. These themes provide guidance on ways to promote the design of feasible and acceptable cross-cultural mHealth tools. ©Sara Simblett, Faith Matcham, Sara Siddi, Viola Bulgari, Chiara Barattieri di San Pietro, Jorge Hortas López, José Ferrão, Ashley Polhemus, Josep Maria Haro, Giovanni de Girolamo, Peter Gamble, Hans Eriksson, Matthew Hotopf, Til Wykes, RADAR-CNS Consortium. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 30.01.2019.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

  • Siddi, Sara|||0000-0002-1494-9028
  • Giné-Vázquez, Iago|||0000-0002-6725-2638
  • Bailón, Raquel|||0000-0003-1272-0550
  • Matcham, Faith
  • Lamers, Femke|||0000-0003-4344-5766
  • Kontaxis, Spyridon|||0000-0002-1297-0691
  • Laporta, Estela|||0000-0001-6776-8522
  • Garcia, Esther|||0000-0003-3997-493X
  • Arranz, Belén|||0000-0003-3927-8803
  • Dalla Costa, Giancarlo
  • Guerrero, Ana Isabel|||0000-0001-5891-2123
  • Zabalza, Ana|||0000-0003-3860-5251
  • Buron, Mathias Due|||0000-0003-1260-1156
  • Comi, Giancarlo|||0000-0002-6989-1054
  • Leocani, Letizia|||0000-0001-9326-6753
  • Annas, Peter
  • Hotopf, Matthew|||0000-0002-3980-4466
  • Penninx, Benda W. J.
  • Magyari, Melinda|||0000-0002-0972-5222
  • Sørensen, Per S.|||0000-0002-2818-3780
  • Montalban, Xavier|||0000-0002-0098-9918
  • Lavelle, Grance
  • Ivan, Alina
  • Oetzmann, Carolin|||0000-0003-1480-917X
  • White, katie M.
  • Difrancesco, Sonia|||0000-0001-7254-3686
  • Locatelli, Patrick|||0000-0002-3796-8512
  • Mohr, David C.
  • Aguiló Llobet, Jordi|||0000-0002-4691-5754
  • Narayan, Vaibhav
  • Folarin, Amoros|||0000-0002-0333-1927
  • Dobson, Richard James Butler|||0000-0003-4224-9245
  • Dineley, Judith
  • Leightley, Daniel|||0000-0001-9512-752X
  • Cummins, Nicholas
  • Vairavan, Srinivasan
  • Ranjan, Yathart
  • Rashid, Zulqarnain
  • Rintala, Aki
  • Girolamo, Giovanni De
  • Preti, Antonio|||0000-0001-9003-9838
  • Simblett, Sara
  • Wykes, Til|||0000-0002-5881-8003
  • Myin-Germeys, Inez|||0000-0002-3731-4930
  • Haro Abad, Josep Maria|||0000-0002-3984-277X
Changes in lifestyle, finances and work status during COVID-19 lockdownsmay have led to biopsychosocial changes in people with pre-existing vulnerabilities such as MajorDepressive Disorders (MDDs) and Multiple Sclerosis (MS). Methods: Data were collected as a part the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program.We analyzed the following data from long-term participants in a decentralized multinational study:J. Clin. Med. 2022, 11, 7163. https://doi.org/10.3390/jcm11237163 https://www.mdpi.com/journal/jcm J. Clin. Med. 2022, 11, 7163 2 of 20 symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state,steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Results: Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall,depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Conclusions: Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Impact of COVID-19 Lockdown on Adults with Major Depressive Disorder from Catalonia, A Decentralized Longitudinal Study

  • Lavalle, Raffaele
  • Condominas, Elena|||0000-0002-7178-8398
  • Haro Abad, Josep Maria|||0000-0002-3984-277X
  • Giné-Vázquez, Iago|||0000-0002-6725-2638
  • Bailón, Raquel|||0000-0003-1272-0550
  • Laporta, Estela|||0000-0001-6776-8522
  • García Pagès, Esther|||0000-0002-9225-845X
  • Kontaxis, Spyridon|||0000-0002-1297-0691
  • Riquelme Alacid, Gemma|||0000-0002-6813-3577
  • Lombardini, Federica|||0000-0002-7856-8646
  • Preti, Antonio|||0000-0001-9003-9838
  • Peñarrubia-Maria, Maria Teresa|||0000-0002-0322-4961
  • Coromina, Marta
  • Arranz, Belén|||0000-0003-3927-8803
  • Vilella, Elisabet|||0000-0002-1887-5919
  • Rubio-Abadal, Elena|||0000-0002-5845-5636
  • Matcham, Faith Alexandra Elisabeth|||0000-0002-4055-904X
  • Lamers, Femke|||0000-0003-4344-5766
  • Hotopf, Matthew|||0000-0002-3980-4466
  • Penninx, Brenda WJH.|||0000-0001-7779-9672
  • Annas, Peter
  • Narayan, Vaibhav
  • Simblett, Sara Katherine|||0000-0002-8075-8238
  • Siddi, Sara|||0000-0002-1494-9028
The present study analyzes the effects of each containment phase of the first COVID-19 wave on depression levels in a cohort of 121 adults with a history of major depressive disorder (MDD) from Catalonia recruited from 1 November 2019, to 16 October 2020. This analysis is part of the Remote Assessment of Disease and Relapse-MDD (RADAR-MDD) study. Depression was evaluated with the Patient Health Questionnaire-8 (PHQ-8), and anxiety was evaluated with the Generalized Anxiety Disorder-7 (GAD-7). Depression's levels were explored across the phases (pre-lockdown, lockdown, and four post-lockdown phases) according to the restrictions of Spanish/Catalan governments. Then, a mixed model was fitted to estimate how depression varied over the phases. A significant rise in depression severity was found during the lockdown and phase 0 (early post-lockdown), compared with the pre-lockdown. Those with low pre-lockdown depression experienced an increase in depression severity during the "new normality", while those with high pre-lockdown depression decreased compared with the pre-lockdown. These findings suggest that COVID-19 restrictions affected the depression level depending on their pre-lockdown depression severity. Individuals with low levels of depression are more reactive to external stimuli than those with more severe depression, so the lockdown may have worse detrimental effects on them.